Updated:
Hidragon Capital
Hidragon Capital, dba Qianlong Investment, is a private equity fund managing company based in China. It has made 11 investments, including a 2021 investment...
Overview
Hidragon Capital, dba Qianlong Investment, is a private equity fund managing company based in China. It has made 11 investments, including a 2021 investment in Baicare. The company has 2 portfolio exits, with Vigonvita being its most recent exit on November 06, 2025.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What investment stages does Hidragon Capital typically target?
The firm focuses on early-stage venture, including seed, startup, and general venture rounds. It does not participate in growth-stage or late-stage deals. Its stage focus is narrower than many multi-stage private equity firms in China.
Where does the underlying capital come from for Hidragon Capital?
The source of capital—whether institutional, family-office, or high-net-worth—is not publicly disclosed. The firm's wealth origin is not published, making it difficult to assess LP concentration or any single-family influence.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: